0
likes
0
comments
daily view 0
monthly view 0
Live Analytics
Comments 0
Dr. Saad on the Safety Profile of Apalutamide in M0CRPC Analytics Table
Income Estimates for Dr. Saad on the Safety Profile of Apalutamide in M0CRPC
Based on this YouTube video's total view count of 245 views and industry-standard rates, the estimated total earning is $0 - $0 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About Dr. Saad on the Safety Profile of Apalutamide in M0CRPC
Explore Dr. Saad on the Safety Profile of Apalutamide in M0CRPC with 245 views, 0 likes, and 0 comments. Experience the impact of this video content that has captured audience attention.
Fred Saad, MD, FRCS, discusses the safety profile of apalutamide in nonmetastatic castration-resistant prostate cancer. Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: https://www.linkedin.com/company/onclive
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard